Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Asselah

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Gut|January 5, 2002
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot studyR Moreau, T Asselah, B Condat, et al.
Bone Marrow Transplantation|August 3, 2005
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipientsR Peffault de Latour, T Asselah, V Lévy, et al.
Gut|October 23, 2003
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis CT Asselah, N Boyer, M-C Guimont, et al.
Journal of Viral Hepatitis|March 6, 2002
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosisManuela G Neuman, J P Benhamou, I M Malkiewicz, et al.
Journal of Viral Hepatitis|October 15, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patientsQ Zhang, M Lapalus, T Asselah, et al.
Journal of Viral Hepatitis|October 7, 2017
Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4G Camus, B Han, T Asselah, et al.
Alimentary Pharmacology & Therapeutics|November 29, 2017
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3Z M Younossi, M Stepanova, I M Jacobson, et al.
Journal of Viral Hepatitis|March 16, 2017
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertensionN Afdhal, G T Everson, J L Calleja, et al.
Clinical Biochemistry|June 16, 2001
Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis CM G Neuman, J P Benhamou, I M Malkiewicz, et al.
Journal of Viral Hepatitis|November 18, 2015
Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirinG R Foster, P Ferenci, T Asselah, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Gut|January 5, 2002
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot studyR Moreau, T Asselah, B Condat, et al.
Bone Marrow Transplantation|August 3, 2005
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipientsR Peffault de Latour, T Asselah, V Lévy, et al.
Gut|October 23, 2003
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis CT Asselah, N Boyer, M-C Guimont, et al.
Journal of Viral Hepatitis|March 6, 2002
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosisManuela G Neuman, J P Benhamou, I M Malkiewicz, et al.
Journal of Viral Hepatitis|October 15, 2013
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patientsQ Zhang, M Lapalus, T Asselah, et al.
Journal of Viral Hepatitis|October 7, 2017
Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4G Camus, B Han, T Asselah, et al.
Alimentary Pharmacology & Therapeutics|November 29, 2017
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3Z M Younossi, M Stepanova, I M Jacobson, et al.
Journal of Viral Hepatitis|March 16, 2017
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertensionN Afdhal, G T Everson, J L Calleja, et al.
Clinical Biochemistry|June 16, 2001
Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis CM G Neuman, J P Benhamou, I M Malkiewicz, et al.
Journal of Viral Hepatitis|November 18, 2015
Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirinG R Foster, P Ferenci, T Asselah, et al.
Pageof 5